Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 10 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for Evolent Health Inc have a median target of 23.50, with a high estimate of 47.21 and a low estimate of 16.00. The median estimate represents a 107.78% increase from the last price of 11.31.
High | 317.4% | 47.21 |
Med | 107.8% | 23.50 |
Low | 41.5% | 16.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | -18.48% |
Average growth rate | +1,570.80% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.26% |
Average growth rate | +25.87% |
More ▼